Dexcom G6 Intervention Study
Dexcom G6 Intervention Study
The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to
 guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour
 assessment of glucose values compared to Point of Care (POC) testing, during hospitalization
 and after hospital discharge in general medicine and surgery patients with T2D and T1D
The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to
 guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour
 assessment of glucose values compared to Point of Care (POC) testing, during hospitalization
 and after hospital discharge in general medicine and surgery patients with T2D and T1D.
Inclusion Criteria:

 1. Males and females ≥ 18 years admitted to a general medicine or surgical services.

 2. History of T1D or T2D receiving insulin therapy during hospital admission.

 3. Subjects must have a randomization BG <400 mg/dL without laboratory evidence of
 diabetic ketoacidosis (bicarbonate < 18 mEq/L, pH < 7.30, or positive serum or urinary
 ketones).

 4. Patients with expected hospital length-of-stay of 3 or more day

 Exclusion Criteria:

 1. Patients with acute illness admitted to the ICU or expected to require admission to
 the ICU.

 2. Patients expected to require MRI procedures during hospitalization.

 3. Patients with clinically relevant hepatic disease (diagnosed liver cirrhosis and
 portal hypertension), corticosteroid therapy, end-stage renal disease (dialysis), or
 anasarca (massive peripheral edema).

 4. Mental condition rendering the subject unable to understand the nature, scope, and
 possible consequences of the study.

 5. Female subjects who are pregnant or breast-feeding at time of enrollment into the
 study.